White Women Overrepresented in Gynecologic Cancer Trials
By Lori Solomon HealthDay Reporter
TUESDAY, Dec. 12, 2023 -- White women are disproportionately represented in clinical trials for gynecologic cancers, according to a study published online Dec. 7 in JAMA Network Open.
Wafa Khadraoui, M.D., from The Ohio State University in Columbus, and colleagues examined the association of race and ethnicity with clinical trial enrollment among women with endometrial, ovarian, or cervical cancer. The analysis included data the National Cancer Database and the Surveillance, Epidemiology, and End Results Program. Data were from 562,592 patients with gynecologic cancer diagnosed from 2004 to 2019.
The researchers found that compared with White women, clinical trial enrollment was lower for Asian (odds ratio [OR], 0.44), Black (OR, 0.70), and Hispanic (OR, 0.53) women. White women were adequately or overrepresented for all cancer types compared with the U.S. population (participation-to-prevalence ratio [PPR] ≥1.1). Black women were adequately or overrepresented for endometrial and cervical cancers (PPRs ≥1.1) but underrepresented for ovarian cancer (PPR ≤0.6). Asian and Hispanic women were underrepresented among all three cancer types (PPRs ≤0.6).
"These findings suggest that efforts to engage women with gynecologic cancer who are from minoritized racial and ethnic groups are needed to increase their representation in clinical trials," the authors write.
One author disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted December 2023
Read this next
Lower Prevalence of Employment Seen for Survivors of Childhood Cancer
FRIDAY, May 10, 2024 -- Adult survivors of childhood cancer have declines in employment and increases in health-related unemployment compared with the general population...
Symptom Burden Prevalent in Childhood Cancer Survivors
THURSDAY, May 9, 2024 -- Symptom burden is prevalent among young childhood cancer survivors, with caregiver anxiety and greater neighborhood deprivation associated with greater...
High Rates of Harassment Behaviors Observed in Obstetrics and Gynecology
THURSDAY, May 9, 2024 -- There are high rates of harassment behaviors within the obstetrics and gynecology (OB-GYN) specialty, according to a review published online May 8 in JAMA...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.